Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Comparing Dispersion Techniques to Assess Particle Size

By Drug Discovery Trends Editor | February 22, 2010

Malvern Instruments Morphologi G3Researchers from Solvay Pharmaceuticals Inc. have used the Morphologi G3 image analysis based particle characterization system from Malvern Instruments to examine an API manufactured at two different facilities to determine if—from a particle size and shape perspective—they can be seen as equivalent and be used interchangeably in commercial formulation.

This micronized, highly cohesive API tends to form aggregates, presenting a challenging dispersion problem. To achieve meaningful data and ensure examination of primary particles, it is essential to minimize aggregate formation and disperse discrete particles. A number of dispersion conditions were assessed for image analysis and data were compared with optical microscopy and laser diffraction.

Data generated from dispersions using Morphologi G3’s integral Sample Dispersion Unit (SDU) were the most consistent and reproducible, and the differences compared with other dispersion techniques demonstrated the importance of appropriate method development for any given application. Using the Morphologi G3 software, data were filtered to exclude extraneous particles so only particles of interest were counted. Filtering and classification based on particle size or shape characteristics allowed analysis of particles of interest while excluding those of no importance, in this case large aggregates. The results compared well with laser diffraction and optical microscopy particle size specifications set out by the manufacturer.

The researchers concluded that this dispersion method can be used to assess the particle size of the API for raw material release testing. The method was key in comparing APIs manufactured at two separate facilities to determine that the materials can be considered equivalent.

Date: January 14, 2010
Source: Malvern Instruments 


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE